Nicholson Nur

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 63% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Nicholson Nur's trades of Apellis Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
57.56
Quantity 11,220
Value US$645,838
Transaction date
Proposed sale
Price
65.00
Quantity 2,593
Value US$168,535
Transaction date
Proposed sale
Price
66.81
Quantity 1,857
Value US$124,064
Transaction date
Proposed sale
Price
46.18
Quantity 20,350
Value US$939,690
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-23 2026-01-22
S Sale
88,903 +38.6%
268.17
US$2,365,701 		88,903 +38.6% 268.17 US$2,365,701
2026-01-22 2026-01-22
PrS Proposed sale
7,839
358.68
US$3,877,268 		7,839 358.68 US$3,877,268
2026-01-21 2026-01-20
S Sale
16,063 +37.2%
484.13
US$3,442,578 		16,063 +37.2% 484.13 US$3,442,578
2026-01-20 2026-01-20
PrS Proposed sale
2,203
19.79
US$43,604 		2,203 19.79 US$43,604
2026-01-15 2026-01-13
S Sale
2,618 -3.1%
22.19
US$58,086 		2,618 -3.1% 22.19 US$58,086
2026-01-13 2026-01-13
PrS Proposed sale
2,618
22.19
US$58,086 		2,618 22.19 US$58,086
2025-01-30 2025-01-29
S Sale
825 -1.0%
29.52
US$24,357 		825 -1.0% 29.52 US$24,357
2025-01-29 2025-01-29
PrS Proposed sale
825
29.52
US$24,357 		825 29.52 US$24,357
2025-01-23 2025-01-22
S Sale
3,948 -4.5%
30.43
US$120,120 		3,948 -4.5% 30.43 US$120,120
2025-01-22 2025-01-22
PrS Proposed sale
3,948
30.43
US$120,120 		3,948 30.43 US$120,120
2025-01-21 2025-01-17
S Sale
2,145 -4.0%
29.96
US$64,260 		2,145 -4.0% 29.96 US$64,260
2025-01-17 2025-01-17
PrS Proposed sale
2,145
29.96
US$64,260 		2,145 29.96 US$64,260
2025-01-14 2025-01-13
S Sale
2,632 -4.6%
28.70
US$75,544 		2,632 -4.6% 28.70 US$75,544
2025-01-13 2025-01-13
PrS Proposed sale
2,681
28.70
US$76,935 		2,681 28.70 US$76,935
2024-03-14 2024-03-13
S Sale
3,452 -5.8%
58.13
US$200,677 		3,452 -5.8% 58.13 US$200,677
2024-03-14 2024-03-13
S Sale
7,768 -11.5%
57.31
US$445,161 		7,768 -11.5% 57.31 US$445,161
2024-03-13 2024-03-13
PrS Proposed sale
11,220
57.56
US$645,838 		11,220 57.56 US$645,838
2024-01-31 2024-01-29
S Sale
835 -1.2%
64.14
US$53,555 		835 -1.2% 64.14 US$53,555
2024-01-29 2024-01-29
PrS Proposed sale
835
64.14
US$53,555 		835 64.14 US$53,555
2024-01-23 2024-01-22
S Sale
2,593 -3.7%
65.00
US$168,535 		2,593 -3.7% 65.00 US$168,535
2024-01-22 2024-01-22
PrS Proposed sale
2,593
65.00
US$168,535 		2,593 65.00 US$168,535
2024-01-17 2024-01-16
S Sale
1,857 -2.6%
66.81
US$124,064 		1,857 -2.6% 66.81 US$124,064
2024-01-16 2024-01-16
PrS Proposed sale
1,857
66.81
US$124,064 		1,857 66.81 US$124,064
2023-09-19 2023-09-18
S Sale
10,631 -16.6%
46.15
US$490,589 		10,631 -16.6% 46.15 US$490,589
2023-09-19 2023-09-18
S Sale
9,719 -13.2%
42.21
US$410,224 		9,719 -13.2% 42.21 US$410,224
2023-09-18 2023-09-18
PrS Proposed sale
20,350
46.18
US$939,690 		20,350 46.18 US$939,690